Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amphastar Pharma 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 USA

www.amphastar.com Employees: 1,761 P: 909-980-9484

Description:

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Key Statistics

Overview:

Market Capitalization, $K 1,881,890
Enterprise Value, $K 2,327,380
Shares Outstanding, K 48,081
Annual Sales, $ 644,400 K
Annual Net Income, $ 137,550 K
Last Quarter Sales, $ 191,210 K
Last Quarter Net Income, $ 40,430 K
EBIT, $ 214,260 K
EBITDA, $ 263,690 K
60-Month Beta 0.78
% of Insider Shareholders 27.10%
% of Institutional Shareholders 65.09%
Float, K 35,051
% Float 72.90%
Short Volume Ratio 0.49

Growth:

1-Year Return -33.13%
3-Year Return 73.26%
5-Year Return 103.85%
5-Year Revenue Growth 118.69%
5-Year Earnings Growth 1,338.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.96 on 11/06/24
Next Earnings Date N/A
Earnings Per Share ttm 3.46
EPS Growth vs. Prev Qtr 2.35%
EPS Growth vs. Prev Year -19.44%
Annual Dividend Yield 0.00%
Dividend Payable Date 06/11/10
Dividend Payout Ratio 0.00%

AMPH Ratios

Ratio
Price/Earnings ttm 11.38
Price/Earnings forward 11.03
Price/Earnings to Growth 0.78
Return-on-Equity % 26.45%
Return-on-Assets % 11.89%
Profit Margin % 21.35%
Debt/Equity 0.82
Price/Sales 2.94
Price/Cash Flow 9.02
Price/Book 2.63
Book Value/Share 14.95
Interest Coverage 7.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar